Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / SUPN - Supernus Pharmaceuticals: Virtuous Cycle Of Free Cash Flow Generation To Fund Product Development And Acquisition

SUPN - Supernus Pharmaceuticals: Virtuous Cycle Of Free Cash Flow Generation To Fund Product Development And Acquisition

Supernus Pharmaceuticals Inc.
  • We did a comparison of 3 small-cap biotech stocks (SUPN, ENTA & EGRX) which were ranked highly in our quantitative model.
  • SUPN demonstrated outperformance in growth and profitability metrics.
  • Both SUPN and EGRX are led by Founder-CEO.
  • Overall, we believe SUPN could be a long-term compounder with the upcoming commercialization of new product(s).

For further details see:

Supernus Pharmaceuticals: Virtuous Cycle Of Free Cash Flow Generation To Fund Product Development And Acquisition
Stock Information
Company Name: Supernus Pharmaceuticals Inc.
Stock Symbol: SUPN
Market: NASDAQ
Website: supernus.com
Menu
SUPN SUPN Quote SUPN Short SUPN News SUPN Articles SUPN Message Board
Get SUPN Alerts

News, Short Squeeze, Breakout and More Instantly...